Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.42%-29.38M | -11.22%-8.58M | -38.77%-5.41M | -11.63%-40.75M | 39.86%-6.27M | -31.84%-22.88M | -28.37%-7.71M | -42.93%-3.89M | -143.71%-36.51M | -111.20%-10.42M |
| Net income from continuing operations | -62.26%-25.07M | -9.33%-10.46M | 3.04%-4.37M | -4.20%-34.66M | 27.83%-5.14M | 16.18%-15.45M | -73.39%-9.56M | -105.46%-4.51M | -145.76%-33.26M | -129.97%-7.12M |
| Operating gains losses | ---- | ---- | ---- | ---10K | --0 | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -27.28%116.73K | -45.87%88.48K | 13.58%187.69K | 50.23%675.8K | 12.53%186.57K | -14.82%160.52K | 101.62%163.46K | 1,035.60%165.25K | 1,010.72%449.85K | 1,765.19%165.8K |
| Remuneration paid in stock | 1,280.74%769.14K | -26.43%912.94K | 36.40%767.36K | 4.97%2.41M | -18.53%667.86K | -107.68%-65.14K | 309.03%1.24M | 75.14%562.56K | 213.90%2.29M | 117.15%819.77K |
| Other non cashItems | -26.80%-8.72M | -95.97%-2.27M | -5,895.18%-857.63K | -30.19%-8.52M | 71.65%-496.45K | -124.04%-6.88M | 18.69%-1.16M | 105.01%14.8K | -123.66%-6.54M | -167.86%-1.75M |
| Change In working capital | 646.18%3.45M | 96.15%3.15M | -767.05%-1.13M | -214.95%-643.5K | 41.37%-1.49M | -120.25%-631.47K | 192.59%1.6M | 77.15%-130.64K | -21.28%559.79K | -61.40%-2.54M |
| -Change in receivables | -17.85%-1.24M | 4.87%-240.66K | 515.21%1.01M | -582.27%-975.26K | -75.82%168.61K | -64.30%-1.06M | -21.85%-252.98K | 1,562.12%164.58K | -171.20%-142.94K | 135.33%697.17K |
| -Change in prepaid assets | 154.50%1.8M | -147.65%-2.38M | -3,476.37%-976.64K | 71.70%-52.06K | -70.13%227.81K | -30.87%708.89K | 29.95%-961.45K | 95.45%-27.31K | -564.38%-183.95K | 443.04%762.8K |
| -Change in payables and accrued expense | 1,114.00%2.89M | 104.65%5.77M | -336.18%-1.17M | -56.71%383.82K | 52.87%-1.88M | -110.42%-284.89K | 32.44%2.82M | -1,587.49%-267.91K | 88.36%886.68K | -99.02%-4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.42%-29.38M | -11.22%-8.58M | -38.77%-5.41M | -11.63%-40.75M | 39.86%-6.27M | -31.84%-22.88M | -28.37%-7.71M | -42.93%-3.89M | -143.71%-36.51M | -111.20%-10.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -5,389.49%-714.79K | -7,842.96%-326.14K | -414.55%-406.55K | -165.77%-3.77M | -575.13%-3.67M | 98.02%-13.02K | 96.66%-4.11K | 15.15%-79.01K | 22.92%-1.42M | -836.08%-543.64K |
| Net PPE purchase and sale | -5,389.49%-714.79K | -354.12%-18.65K | -93.23%-152.67K | 81.20%-266.38K | 68.68%-170.24K | 98.02%-13.02K | 96.66%-4.11K | 15.15%-79.01K | 22.92%-1.42M | -836.08%-543.64K |
| Net intangibles purchas and sale | --0 | ---307.49K | ---253.88K | ---3.5M | ---3.5M | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -5,389.49%-714.79K | -7,842.96%-326.14K | -414.55%-406.55K | -165.77%-3.77M | -575.13%-3.67M | 98.02%-13.02K | 96.66%-4.11K | 15.15%-79.01K | 22.92%-1.42M | -836.08%-543.64K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 17.35%610.21K | 33.15%58.07M | -39.52%439.48K | 161.36%45.11M | -38.79%252.21K | -96.94%519.98K | 19,647.25%43.61M | 787.25%726.66K | -64.43%17.26M | -98.83%412.02K |
| Net issuance payments of debt | 84.91%-17.72K | 84.74%-19.44K | 23.89%-127.41K | -41.18%-539.63K | -0.00%-127.41K | 10.72%-117.41K | -3.32%-127.41K | ---167.41K | ---382.22K | ---127.41K |
| Net common stock issuance | --0 | ---- | ---- | 156.41%43.08M | --1 | --0 | ---- | ---- | -65.40%16.8M | --0 |
| Proceeds from stock option exercised by employees | -1.48%627.93K | -29.62%988.76K | -36.59%566.88K | 235.26%3.32M | -14.30%379.61K | 45.19%637.38K | 5,474.87%1.4M | 991.65%894.06K | 82.27%989.06K | 156.59%442.98K |
| Net other financing activities | --0 | ---- | ---- | -406.72%-740.51K | --0 | --0 | ---- | ---- | 74.59%-146.14K | 122.26%96.45K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 17.35%610.21K | 33.15%58.07M | -39.52%439.48K | 161.36%45.11M | -38.79%252.21K | -96.94%519.98K | 19,647.25%43.61M | 787.25%726.66K | -64.43%17.26M | -98.83%412.02K |
| Net cash flow | ||||||||||
| Beginning cash position | 22.63%63.61M | -9.58%14.45M | 3.09%19.82M | -51.80%19.22M | -0.92%29.5M | 68.45%51.87M | -56.99%15.98M | -51.80%19.22M | 387.61%39.89M | 205.72%29.78M |
| Current changes in cash | -31.80%-29.48M | 36.97%49.16M | -65.43%-5.37M | 102.88%594.39K | 8.22%-9.68M | -2,097.09%-22.37M | 664.75%35.89M | -18.67%-3.25M | -165.17%-20.66M | -135.00%-10.55M |
| End cash Position | 15.41%34.05M | 22.63%63.61M | -9.58%14.45M | 3.09%19.82M | 3.09%19.82M | -0.92%29.5M | 68.45%51.87M | -56.99%15.98M | -51.80%19.22M | -51.80%19.22M |
| Free cash from | -31.47%-30.09M | -15.39%-8.91M | -46.24%-5.81M | -17.39%-44.52M | 9.37%-9.94M | -27.10%-22.89M | -25.87%-7.72M | -41.01%-3.97M | -125.49%-37.92M | -119.63%-10.96M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.